The aim is to investigate the relationship between T2-weighted MRI features and clinicopathologic factors in invasive breast cancer.
Analyzed T2-weighted MRI features from patients with invasive breast cancer.
Evaluated correlations with clinical T category and hormone receptor status.
Assessed outcomes related to neoadjuvant treatment and progression.
Significant associations found between MRI features and clinical T category.
MRI features correlated with hormone receptor status and triple-negative breast cancer subtype.
Links established between imaging features and disease progression during treatment.
Abstract
T2-weighted MRI features were associated with clinicopathologic factors, including clinical T category, HR status, triple-negative subtype, and disease progression during NAC.